Related references
Note: Only part of the references are listed.The Role of Serum Osteoprotegerin and S-100 Protein Levels in Patients with Acute Ischaemic Stroke: Determination of Stroke Subtype, Severity and Mortality
M Üstündağ et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Wilbert S. Aronow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromso Study
A. Vik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
NF-kappa B and innate immunity in ischemic stroke
Olivier A. Harari et al.
INNATE INFLAMMATION AND STROKE (2010)
Three-year survival after first-ever ischemic stroke is predicted by initial stroke severity: A hospital-based study
Ku-Chou Chang et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Osteoprotegerin concentrations and prognosis in acute ischaemic stroke
J. K. Jensen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Pathophysiological roles of osteoprotegerin (OPG)
Penny Reid et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2009)
Functional outcome 3 months after stroke predicts long-term survival
Marie Eriksson et al.
CEREBROVASCULAR DISEASES (2008)
Lack of Observed Association between High Plasma Osteoprotegerin Concentrations and Ischemic Stroke Risk in a Healthy Population
Mads Nybo et al.
CLINICAL CHEMISTRY (2008)
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
Torbjorn Omland et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability
Nikolaos P. E. Kadoglou et al.
JOURNAL OF VASCULAR SURGERY (2008)
Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload
Satu Helske et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct
Baburhan Guldiken et al.
THROMBOSIS RESEARCH (2007)
Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro
E. Ben-Tal Cohen et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Enhanced T-cell expression of RANK ligand in acute coronary syndrome -: Possible role in plaque destabilization
WJ Sandberg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE(-/-) mice
Brian J. Bennett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor
ACW Zannettino et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein
EJ Rhee et al.
CLINICAL SCIENCE (2005)
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis
J Golledge et al.
STROKE (2004)
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
S Kiechl et al.
CIRCULATION (2004)
Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
LC Hofbauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Yonsei Stroke Registry - Analysis of 1,000 patients with acute cerebral infarctions
BI Lee et al.
CEREBROVASCULAR DISEASES (2001)
Share Paper
